Chang Zeng

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 4

Top Topics

Diffuse Large B Cell Lymphoma

Patient Reported Outcomes

Top Venues

NPJ genomic medicine

Cancer communications (London, England)

Neuro-oncology advances

This page only lists publications with an associated author ORCID identifier.

Publications

Jiajun Cai, Chang Zeng, Wei Hua, Zengxin Qi, Yanqun Song, Xingyu Lu, Dongdong Li, Zhou Zhang, Xiaolong Cui, Xin Zhang, Zixiao Yang, Jinsen Zhang, Kai Quan, Wei Zhu, Jiabin Cai, Chuan He, Shi-Yuan Cheng, Wei Zhang, Ying Mao
An integrative analysis of genome-wide 5-hydroxymethylcytosines in circulating cell-free DNA detects noninvasive diagnostic markers for gliomas. Neuro-oncology advances 3 (1) (2021)
Brian C-H Chiu, Chang Chen, Qiancheng You, Rudyard Chiu, Girish Venkataraman, Chang Zeng, Sheng Zhang, Xiao-Long Cui, Sonali M Smith, Chuan He, Tripti Khare
Alterations of 5-hydroxymethylation in circulating cell-free DNA reflect molecular distinctions of subtypes of non-Hodgkin lymphoma. NPJ genomic medicine 6 (1) (2021)
Brian C-H Chiu, Zhou Zhang, Qiancheng You, Chang Zeng, Elizabeth Stepniak, Paige M Bracci, Kangkang Yu, Girish Venkataraman, Sonali M Smith, Chuan He, Wei Zhang
Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma. Blood advances 3 (19) (2020)
Chang Zeng, Emily Kunce Stroup, Zhou Zhang, Brian C-H Chiu, Wei Zhang
Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy. Cancer communications (London, England) 39 (1) (2019)